TILRAY BRANDS INC Stock Price, News & Analysis

Tilray Brands' (NASDAQ: TLRY) Shock Top beer brand has partnered with Auntie Anne's, the world's largest soft pretzel franchise, for their "Beer Kneads Pretzels" campaign. The collaboration centers around Shock Top's Twisted Pretzel Wheat beer, which ranked as the #14 new craft beer release in 2024.

The partnership features multiple promotional elements running through December 2025, including: a sweepstakes offering $300 Auntie Anne's gift cards to three winners, a $6 off $12 Auntie Anne's purchase promotion with every Shock Top Twisted Pretzel Wheat 6-pack purchase, and limited-edition merchandise giveaways through social media.

Breckenridge Distillery, owned by Tilray Brands (NASDAQ: TLRY), has announced a strategic distribution partnership with Winebow for the California market. The agreement covers Breckenridge's complete spirits portfolio, including their bourbon whiskey, rum, vodka, gin, and new tequila offerings.

Winebow will manage distribution through their Benicia facility, leveraging their established infrastructure for logistics, sales coverage, and retail activation. The partnership builds on an existing relationship and aligns with Breckenridge's growth strategy in the California market.

Tilray Medical (NASDAQ: TLRY) has announced the expansion of its medical cannabis portfolio in Germany with three new EU-GMP certified strains under the Good Supply brand. The new products include Good Supply Cannabisblüten THC 22 IIM, THC 25 MMK, and THC 18 LLD, which will be available in both 15g and 500g sizes.

The rollout will begin in September 2025, with THC 22 IIM launching first, followed by THC 25 MMK on September 19, and THC 18 LLD by early October. These products will be distributed through Tilray's German logistics network and dispensed by prescription through pharmacies, reinforcing the company's position in Europe's largest medical cannabis market.

Tilray Brands (Nasdaq: TLRY) has successfully regained compliance with Nasdaq's minimum bid price requirement. The company's shares maintained a closing bid price of at least $1.00 for 10 consecutive trading days from August 13, 2025 to August 26, 2025, meeting the listing requirement under Rule 5450(a)(1).

CEO Irwin Simon emphasized the company's commitment to growth and innovation, highlighting Tilray's position as a leader in the cannabis, beverage, and wellness industries. With its global platform and international distribution network, Tilray continues to focus on delivering innovative products and experiences to consumers worldwide.

Breckenridge Distillery, owned by Tilray Brands (NASDAQ: TLRY), has launched Mountain Shot, an innovative mushroom-infused whiskey product. This unique beverage combines whiskey with Japanese maitake mushrooms, featuring chocolate and mint flavors.

Available in both whiskey-based (69 proof) and malt-based (30 proof) varieties, Mountain Shot comes in multiple formats: 750ml bottles, 1-liter bottles, and 100ml resealable pouches. The malt-based version will be distributed through convenience stores. The product is currently available in select U.S. markets.

Tilray Brands (Nasdaq: TLRY) has submitted an application for an extension to regain compliance with Nasdaq's minimum share price listing requirements. The company is considering several options, including a potential stockholder-approved Reverse Stock Split to maintain its Nasdaq listing.

CEO Irwin Simon noted that Tilray's stock has seen recent appreciation following President Trump's cannabis rescheduling review, which he believes reflects investor confidence in the company's global platform. The company aims to leverage its position in cannabis, beverage, and wellness industries while giving the market additional time to recognize its business strategy value.

Tilray Medical (NASDAQ:TLRY) has announced a strategic partnership between its subsidiary FL Group and Molteni, a prominent Italian pharmaceutical company specializing in pain therapies. The collaboration aims to expand access to medical cannabis extracts across Italy.

Through this partnership, Molteni will leverage its extensive network of pharmaceutical, scientific, and medical professionals to provide targeted education on medical cannabis therapies. The initiative combines FL Group's regulatory and distribution expertise with Molteni's scientific leadership to enhance patient care and medical cannabis education for pain management.

Tilray Medical maintains a strong presence in the European medical cannabis market, with operations across Germany, Italy, Portugal, Poland, and the United Kingdom.

Tilray Brands (NASDAQ: TLRY) has expanded its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions for two of its brands. Fizzy Jane's sparkling seltzers, previously available in 5mg format, now offers 10mg HDD9 drinks in Vanilla, Blood Orange, and Lemon Lime flavors across 10 states. Happy Flower introduces its "Super Bloom" Collection, featuring 10mg versions of Margarita, Strawberry Daiquiri, and Peach Bellini cocktails.

Both brands are launching new variety packs and expanding retail presence. Fizzy Jane's is priced at $15.99 per 5mg 4-pack and $17.99 per 10mg 4-pack, while Happy Flower retails for $17.99 for 5mg 4-packs and $19.99 for 10mg options.

Tilray Brands (NASDAQ: TLRY) has announced the launch of its new Whole Wheat Protein Crackers under The Humble Seed brand, exclusively at select Whole Foods Market stores nationwide. The crackers feature 5g of plant-based protein per serving and are available in three flavors: Sea Salt, Garlic Herb, and Rosemary Sea Salt.

The innovative snack combines a blend of superseeds (hemp, chia, flax, pumpkin, sesame, and sunflower) with whole wheat flour. Each 30g serving contains approximately 21 bite-sized crackers. The products are plant-based, Non-GMO Project Verified, Kosher, and soy-free, targeting the growing market demand for protein-rich snack alternatives.